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Volume 56, Number 3 Abstracts 877Summary: More than 100 years ago, Trousseau reported migratory
thrombophlebitis in cancer patients (Trosseau A, Lectures on Clinical Med-
icine, delivered at the Hotel-Dieu, Paris, London: New Sydenham Society;
1872; p 281-95). Subsequently, patients with DVT or pulmonary embolism
(PE) have been shown to have up to a fourfold increased risk of cancer in the
first year after the venous thromboembolic (VTE) event (Baron JA et al, Br J
Cancer 2004;91:92-5). However, only one previous study has investigated
the relationship between SVT and cancer risk (van Doormaal FF et al, Ann
FamMed 2010;8:47-50). In an effort to understand the broader cancer risk
associated with all types of venous thrombosis, the authors used population-
based registries in Denmark to investigate associations of cancer with SVT,
DVT, and PE. They identified all patients in Denmark from 1994 to 2009
with a diagnosis of SVT, DVT in the legs, or PE. The occurrence of cancer
in each of the venous cohorts was compared with expected numbers of cases
using national incidence rates to compute standardized incidence ratios
(SIRs). The authors identified 763 patients with SVT, 45,252 with DVT,
and 24,332 with PE. Very similar proportions of patients in the three
cohorts in the first year of follow-up were diagnosed with cancer. The SIRs
(95% confidence intervals) were 2.46 (2.10-2.86) for SVT, 2.75 (2.6-2.9)
for DVT, and 3.27 (3.03-3.52) for PE, and declined after 1 year to 1.05
(0.96-1.16), 1.11 (1.07-1.16), and 1.15 (1.09-1.22), respectively. Venous
thrombotic cohorts showed strong associations for particular cancers (liver,
lung, ovaries, pancreas, and non-Hodgkin lymphoma).
Comment: The key point here is that all forms of lower extremity
venous thrombosis, SVT, DVT, and potential sequelae, such as PE, are
markers for a clearly higher occurrence rate of cancer, particularly during the
first year after diagnosis. Practical implications for screening for cancer in
patients with VTE are unclear. If someone has cancer and a VTE event
within 1 year of diagnosis, the prognosis is poor, with only a 12% survival
(Sorensen HT et al, N Engl J Med 2000;343:1846-50). However, the
implications for screening derived from this particular study are also unclear.
The authors point out 45,981 individuals with VTE would have to be
investigated to find 304 excess cancers during the first year of follow-up.
That is a lot of investigation for not many cancers, especially when it is
unclear that an early cancer diagnosis stemming from evaluation of a VTE
event would ultimately prolong the life of a VTE patient with underlying
cancer.
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Conclusion: Carotid endarterectomy (CEA) performed for a qualify-
ing neurologic event within 0 to 2 days has a significantly increased periop-
erative risk than CEA performed from day 3 on.
r
wSummary: Data indicate the risk of stroke after a transient ischemic
ttack is 6.7% at 2 days and 10% at 7 days (Giles MF et al, Lancet Neurol
007;6:1063-72). Analysis from CEA trials indicates that benefit from
urgery for symptomatic patients is greatest 14 days of the most recent
ymptom and falls rapidly with delay of surgery (Rothwell PM et al, Lancet
004;363:915-24). CEA is therefore recommended early after a qualifying
eurologic event. However, studies reporting a risk for CEA within 0 to 2
ays after a qualifying neurologic event are few and contain only a small
umber of patients (Rantner B, Eur J Vasc Endovasc Surg 2005;30:36-40;
alem MK et al, Eur J Vasc Endovasc Surg 2011;41:222-8). In this study,
he authors use the Swedish Vascular Registry to determine how the time
etween neurologic event and CEA affected procedural risk of mortality and
troke. The Swedish Vascular Registry has been nationwide since 1994 and
ncludes all 22 vascular centers in Sweden performing CEA. The authors
rospectively analyzed data on all patients who underwent CEA for symp-
omatic carotid stenosis between May 12, 2008, and May 31, 2011, using
ecords from the Swedish Vascular Registry. Patients were divided by time
etween the qualifying event and surgery (0-2, 3-7, 8-14, and 15-180 days).
ualifying events were categorized as amaurosis fugax, hemispheric TIA,
rescendo TIA, minor stroke (symptoms resolved 1 week or remaining
inor dysfunction), or major stroke (disabling stroke). In each of the timing
ubgroups, stroke rate and mortality 30 days after surgery were determined.
ultivariate analysis was used to determine independent risk factors for
erioperative complications. The study assessed 2,596 patients. The com-
ined mortality and stroke rate for patients treated 0 to 2 days after a
ualifying event was 11.5% (17 of 148) vs 3.6% (29 of 804), 4.0% (27 of
77), and 5.4% (52 of 967) for the groups treated between 3-7, 8-14, and
5-180 days, respectively. Multivariate analysis showed time was an inde-
endent risk factor for perioperative complications, with patients treated in
to 2 days having a relative odds ratio of 4.25 (95% confidence interval,
.07-8.70; P  .001) compared with the reference group treated at 3 to 7
ays. There was no increased risk for patients treated 8 to 14 days after the
ualifying event compared with the reference group. The group treated 15
o 180 days after an event also showed a significantly increase risk compared
ith the reference group (odds ratio, 1.90). Diabetes and female sex were
ndependent predictors of increased risk. Using hemispheric TIA as the
eference event, crescendo TIA, minor stroke, and major stroke were not
ualifying factors for increased risk, but amaurosis fugax was a qualifying
actor for reduced risk (P  .001).
Comment: The study strength is that it analyzes 93% of all CEAs
erformed in Sweden during the interval described. However, the patients
ere not randomized, and unmeasured confounding variables might have
nfluenced the results. In addition, these are registry data and are self-
eported. The data do suggest caution in performing very urgent CEA in
ymptomatic patients. The authors conclude, “more studies of procedural
isk in this time period are required before general recommendations on
hen extremely early intervention can be given.”
